Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleBehavioral Pharmacology

Potent Inhibition of Alcohol Self-Administration in Alcohol-Preferring Rats by a κ-Opioid Receptor Antagonist

John R. Cashman and Marc R. Azar
Journal of Pharmacology and Experimental Therapeutics July 2014, 350 (1) 171-180; DOI: https://doi.org/10.1124/jpet.114.214262
John R. Cashman
Human BioMolecular Research Institute, San Diego, California (J.R.C.); and Behavioral Pharma, Inc., La Jolla, California (M.R.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc R. Azar
Human BioMolecular Research Institute, San Diego, California (J.R.C.); and Behavioral Pharma, Inc., La Jolla, California (M.R.A.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 350 no. 1 171-180
DOI 
https://doi.org/10.1124/jpet.114.214262
PubMed 
24817033

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received February 25, 2014
  • Accepted May 8, 2014
  • Published online June 5, 2014.

Article Versions

  • Earlier version (May 9, 2014 - 11:54).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. John R. Cashman and
  2. Marc R. Azar
  1. Human BioMolecular Research Institute, San Diego, California (J.R.C.); and Behavioral Pharma, Inc., La Jolla, California (M.R.A.)
  1. Address correspondence to:
    Dr. John R. Cashman, Human BioMolecular Research Institute, 5310 Eastgate Mall, San Diego, CA 92121. E-mail: jcashman{at}hbri.org
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2014 to January 2021

AbstractFullPdf
May 2014175080
Jun 20145253551
Jul 2014124916
Aug 201453612
Sep 20141321311
Oct 20142446
Nov 20143053
Dec 20143955
Jan 20157347
Feb 20152612
Mar 20152272
Apr 20152722
May 20151441
Jun 20151504
Jul 20151328
Aug 20151922
Sep 20152242
Oct 2015776
Nov 20151436
Dec 20152115
Jan 2016778
Feb 2016829
Mar 201614818
Apr 20161249
May 20164310
Jun 201621120
Jul 201610223
Aug 201619421
Sep 2016549
Oct 20160813
Nov 201651014
Dec 20160104
Jan 2017157
Feb 2017270
Mar 20170107
Apr 20170115
May 201711219
Jun 20170101
Jul 2017372
Aug 2017082
Sep 20171109
Oct 2017052
Nov 20170164
Dec 2017084
Jan 2018068
Feb 2018073
Mar 2018095
Apr 20180124
May 20180148
Jun 20180137
Jul 20180134
Aug 2018061
Sep 2018199
Oct 20180411
Nov 20180410
Dec 2018165
Jan 20190511
Feb 20192116
Mar 201901313
Apr 2019258
May 20190412
Jun 20198010
Jul 20191202
Aug 20191600
Sep 20191210
Oct 20191800
Nov 20192201
Dec 2019580
Jan 2020272
Feb 2020184
Mar 2020063
Apr 2020033
May 2020092
Jun 2020421
Jul 20201800
Aug 2020701
Sep 2020200
Oct 20201401
Nov 20201001
Dec 2020810
Jan 20211110

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 350 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 350, Issue 1
1 Jul 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Potent Inhibition of Alcohol Self-Administration in Alcohol-Preferring Rats by a κ-Opioid Receptor Antagonist
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleBehavioral Pharmacology

Potent Alcohol Cessation Agents

John R. Cashman and Marc R. Azar
Journal of Pharmacology and Experimental Therapeutics July 1, 2014, 350 (1) 171-180; DOI: https://doi.org/10.1124/jpet.114.214262

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleBehavioral Pharmacology

Potent Alcohol Cessation Agents

John R. Cashman and Marc R. Azar
Journal of Pharmacology and Experimental Therapeutics July 1, 2014, 350 (1) 171-180; DOI: https://doi.org/10.1124/jpet.114.214262
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Concentration-response analysis human taste discrimination
  • Varenicline and epibatidine as opioid adjuvants
  • MCAM reverses and prevents fentanyl ventilatory depression
Show more Behavioral Pharmacology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics